Product
Autologous Cytomegalovirus-specific Cytotoxic T-lymphocytes
1 clinical trial
5 indications
Indication
CytomegalovirusIndication
GlioblastomaIndication
GliosarcomaIndication
Malignant GliomaIndication
Brain NeoplasmClinical trial
A Phase I/II Clinical Trial of Autologous CMV-Specific Cytotoxic T Cells for GBM PatientsStatus: Completed, Estimated PCD: 2022-02-23